These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 38174117)

  • 1. Stage-specific treatment of colorectal cancer: A microRNA-nanocomposite approach.
    Fadaka AO; Akinsoji T; Klein A; Madiehe AM; Meyer M; Keyster M; Sikhwivhilu LM; Sibuyi NRS
    J Pharm Anal; 2023 Nov; 13(11):1235-1251. PubMed ID: 38174117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of microRNA in colorectal carcinoma (CRC): a narrative review.
    Sado AI; Batool W; Ahmed A; Zafar S; Patel SK; Mohan A; Zia U; Aminpoor H; Kumar V; Tejwaney U
    Ann Med Surg (Lond); 2024 Jan; 86(1):308-318. PubMed ID: 38222721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNAs as potential drug targets for therapeutic intervention in colorectal cancer.
    Jafri MA; Zaidi SK; Ansari SA; Al-Qahtani MH; Shay JW
    Expert Opin Ther Targets; 2015; 19(12):1705-23. PubMed ID: 26189482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting miRNA and using miRNA as potential therapeutic options to bypass resistance in pancreatic ductal adenocarcinoma.
    Vahabi M; Dehni B; Antomás I; Giovannetti E; Peters GJ
    Cancer Metastasis Rev; 2023 Sep; 42(3):725-740. PubMed ID: 37490255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of MicroRNAs in Inflammation-Associated Colorectal Cancer: A Mechanistic Approach.
    Muthusami S; Ramachandran I; Krishnamoorthy S; Sambandam Y; Ramalingam S; Queimado L; Chaudhuri G; Ramachandran IK
    Endocr Metab Immune Disord Drug Targets; 2021; 21(1):67-76. PubMed ID: 32940190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNAs in the prognosis and therapy of colorectal cancer: From bench to bedside.
    To KK; Tong CW; Wu M; Cho WC
    World J Gastroenterol; 2018 Jul; 24(27):2949-2973. PubMed ID: 30038463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA in colorectal cancer: new perspectives for diagnosis, prognosis and treatment.
    Bonfrate L; Altomare DF; Di Lena M; Travaglio E; Rotelli MT; De Luca A; Portincasa P
    J Gastrointestin Liver Dis; 2013 Sep; 22(3):311-20. PubMed ID: 24078989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The significance of microRNA deregulation in colorectal cancer development and the clinical uses as a diagnostic and prognostic biomarker and therapeutic agent.
    Ahadi A
    Noncoding RNA Res; 2020 Sep; 5(3):125-134. PubMed ID: 32954092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Co-delivery of 5-fluorouracil and miRNA-34a mimics by host-guest self-assembly nanocarriers for efficacious targeted therapy in colorectal cancer patient-derived tumor xenografts.
    Xu J; Zhang G; Luo X; Wang D; Zhou W; Zhang Y; Zhang W; Chen J; Meng Q; Chen E; Chen H; Song Z
    Theranostics; 2021; 11(5):2475-2489. PubMed ID: 33500737
    [No Abstract]   [Full Text] [Related]  

  • 10. Biomarkers for Stratification in Colorectal Cancer: MicroRNAs.
    Fadaka AO; Pretorius A; Klein A
    Cancer Control; 2019; 26(1):1073274819862784. PubMed ID: 31431043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Triumph against cancer: invading colorectal cancer with nanotechnology.
    Vinchhi P; Patel MM
    Expert Opin Drug Deliv; 2021 Sep; 18(9):1169-1192. PubMed ID: 33567909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Review on the Role of Nanosensors in Detecting Cellular miRNA Expression in Colorectal Cancer.
    Girigoswami K; Girigoswami A
    Endocr Metab Immune Disord Drug Targets; 2021; 21(1):12-26. PubMed ID: 32410567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dissecting miRNA signature in colorectal cancer progression and metastasis.
    Huang X; Zhu X; Yu Y; Zhu W; Jin L; Zhang X; Li S; Zou P; Xie C; Cui R
    Cancer Lett; 2021 Mar; 501():66-82. PubMed ID: 33385486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNAs as Therapeutic Targets and Colorectal Cancer Therapeutics.
    Yamamoto H; Mori M
    Adv Exp Med Biol; 2016; 937():239-47. PubMed ID: 27573904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNAs in colorectal cancer: from diagnosis to targeted therapy.
    Orang AV; Barzegari A
    Asian Pac J Cancer Prev; 2014; 15(17):6989-99. PubMed ID: 25227782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of global microRNA expression reveals oncogenic potential of miR-145 in metastatic colorectal cancer.
    Arndt GM; Dossey L; Cullen LM; Lai A; Druker R; Eisbacher M; Zhang C; Tran N; Fan H; Retzlaff K; Bittner A; Raponi M
    BMC Cancer; 2009 Oct; 9():374. PubMed ID: 19843336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of dietary components on miRNA and colorectal carcinogenesis.
    Fadaka AO; Ojo BA; Adewale OB; Esho T; Pretorius A
    Cancer Cell Int; 2018; 18():130. PubMed ID: 30202241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNAs that regulate PTEN as potential biomarkers in colorectal cancer: a systematic review.
    Liu J; Ke F; Chen T; Zhou Q; Weng L; Tan J; Shen W; Li L; Zhou J; Xu C; Cheng H; Zhou J
    J Cancer Res Clin Oncol; 2020 Apr; 146(4):809-820. PubMed ID: 32146564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. microRNA expression profile in stage III colorectal cancer: circulating miR-18a and miR-29a as promising biomarkers.
    Brunet Vega A; Pericay C; Moya I; Ferrer A; Dotor E; Pisa A; Casalots À; Serra-Aracil X; Oliva JC; Ruiz A; Saigí E
    Oncol Rep; 2013 Jul; 30(1):320-6. PubMed ID: 23673725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-411 inhibits malignant biological behaviours of colorectal cancer cells by directly targeting PIK3R3.
    Zhao J; Xu J; Zhang R
    Oncol Rep; 2018 Feb; 39(2):633-642. PubMed ID: 29207180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.